PMC:7275137 / 21720-21785
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T93","span":{"begin":5,"end":27},"obj":"Body_part"}],"attributes":[{"id":"A93","pred":"fma_id","subj":"T93","obj":"http://purl.org/sig/ont/fma/fma55675"}],"text":"Many central nervous system drugs have lysosomotropic properties."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T9","span":{"begin":5,"end":27},"obj":"Body_part"},{"id":"T10","span":{"begin":13,"end":27},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0001016"}],"text":"Many central nervous system drugs have lysosomotropic properties."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T136","span":{"begin":5,"end":27},"obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"T137","span":{"begin":5,"end":27},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T138","span":{"begin":5,"end":27},"obj":"http://www.ebi.ac.uk/efo/EFO_0000908"}],"text":"Many central nervous system drugs have lysosomotropic properties."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T168","span":{"begin":28,"end":33},"obj":"Chemical"}],"attributes":[{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Many central nervous system drugs have lysosomotropic properties."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T111","span":{"begin":0,"end":65},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Many central nervous system drugs have lysosomotropic properties."}